Call for Abstract

7th International Conference on Central Nervous System Disorders and Therapeutics, will be organized around the theme “Accelerate the Diagnosis, Prevention & Management of CNS Disorders”

CNS Disorders 2022 is comprised of 19 tracks and 2 sessions designed to offer comprehensive sessions that address current issues in CNS Disorders 2022.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Cognitive neuroscience is the scientific field that is concerned with the study of the biological processes and aspects that underlie cognition, with a specific focus on the neural connections in the brain which are involved in mental processes. It addresses the questions of how cognitive activities are affected or controlled by neural circuits in the brain. Cognitive neuroscience is a branch of both neuroscience and psychology, overlapping with disciplines such as behavioural neuroscience, cognitive psychology, physiological psychology and affective neuroscience. Cognitive neuroscience relies upon theories in cognitive science coupled with evidence from neurobiology, and computational modelling.


  • Track 1-1Neurocognitive
  • Track 1-2Cognition Psychology
  • Track 1-3Evolution and Social Cognition
  • Track 1-4Cognitive Development
  • Track 1-5Methods of cognitive Neuroscience
  • Track 1-6Neurobehavioral and Cognitive Disorders
  • Track 1-7Cognitive Genomics & Behavioural Genetics
  • Track 1-8Cognitive Rehabilitation Therapy

MOG antibody disease (MOGAD) is a recently coined neuro-inflammatory condition that preferentially causes inflammation in the optic nerve but can also cause inflammation in the spinal cord and brain. Myelin oligodendrocyte glycoprotein (MOG) is a protein that is located on the surface of myelin sheaths in the central nervous system. While the function of this glycoprotein is not exactly known, MOG is a target of the immune system in this disease. The diagnosis is confirmed when MOG antibodies in the blood are found in patients who have repeated inflammatory attacks of the central nervous system.


  • Track 2-1Neuromyelitis Optica Spectrum Disorder (NMOSD)
  • Track 2-2Transverse Myelitis (TM)
  • Track 2-3Acute Disseminated Encephalomyelitis (ADEM)
  • Track 2-4Optic Neuritis (ON)

Neuroscience nurses care for people with a variety of neurological conditions and disorders across the lifespan and in all health care settings. There are many specialities encompassed within this field of practice. Most people with long-term neurological conditions live active and fulfilling lives and are cared for out of hospital, but may require admission to hospital for reasons that may or may not be related to their disorder. Many people will be supported by a specialist nurse and nursing team during their hospital stay.


  • Track 3-1Advance Practice Nursing
  • Track 3-2Acute Ischemic Stroke Patients
  • Track 3-3Pediatrics Nursing
  • Track 3-4Neuroscience Nursing
  • Track 3-5Trauma & Critical Care Nursing

Biomarkers provide detailed measures of abnormal changes in the brain, which can aid in early detection of possible disease in people with very mild or unusual symptoms. People with Alzheimer's disease and related dementias progress at different rates, and biomarkers may help predict and monitor their progression.


  • Track 4-1 Neuroimaging Enrichment for CNS Disease
  • Track 4-2CNS Drug Development Using Biomarkers
  • Track 4-3 Cerebro Spinal Fluid Biomarkers
  • Track 4-4Biomarker Challenges in Rare Diseases

CNS clinical trials bring specific challenges, including managing placebo response, incorporating soft endpoints, and require a particular focus on reducing patient burden. Unsurprisingly this had led to a challenging of accepted and established norms by CNS drug developers.


  • Track 5-1Alzheimer’s Disease and Cognition Clinical Trial
  • Track 5-2Neurology Clinical Trial
  • Track 5-3Pain Management and Analgesia Clinical Trial
  • Track 5-4Psychiatry Clinical Trial

The CNS consists of the brain and spinal cord. The brain is protected by the skull (the cranial cavity) and the spinal cord travels from the back of the brain, down the centre of the spine, stopping in the lumbar region of the lower back. The brain and spinal cord are both housed within a protective triple-layered membrane called the meninges. The central nervous system has been thoroughly studied by anatomists and physiologists, but it still holds many secrets; it controls our thoughts, movements, emotions, and desires. It also controls our breathing, heart rate, the release of some hormones, body temperature, and much more. The retina, optic nerve, olfactory nerves, and olfactory epithelium are sometimes considered to be part of the CNS alongside the brain and spinal cord. This is because they connect directly with brain tissue without intermediate nerve fibres.


  • Track 6-1Case Studies Related To CNS Disorders
  • Track 6-2Case Studies on Child Neurology
  • Track 6-3Case Studies on Neuroimmunology
  • Track 6-4Case Studies on Neuro-Oncology
  • Track 6-5Case Reports on Brain Tumour
  • Track 6-6Case Studies on Cerebrovascular Disorders
  • Track 6-7Case Reports Related To Neuroimmunology Diseases

Computational neuroscience (also known as theoretical neuroscience or mathematical neuroscience) is a branch of neuroscience which employs mathematical models, theoretical analysis and abstractions of the brain to understand the principles that govern the development, structure, physiology and cognitive abilities of the nervous system. Computational neuroscience involves studying brain function through computer modeling and mathematical analysis. Computational neuroscientists perform research in which they collect data and create computer models based on the electrical patterns and biological functions of the brain.


  • Track 7-1Neuroinformatics
  • Track 7-2Neural Science And Behavior
  • Track 7-3Computational Drug Response Models
  • Track 7-4Neural Network Theory & Models
  • Track 7-5Neural Network Applications
  • Track 7-6Neuro Engineering

The Novel Drug Discovery Program focuses on activity guided isolation and structure elucidation of bioactive compounds from natural sources with high throughput screening. The program includes synthesis of bioactive compounds, analogues and internal standards for further drug development and bioavailability studies. Novel therapies are therapies entirely new to veterinary medicine either because they are genuinely novel and have not been previously used in the context of a medicine, or new only to the veterinary domain, although well known in terms of research, and possibly in the context of human medicine.


  • Track 8-1Anti-Neurodegenerative Drug Discovery
  • Track 8-2Ion Channels, Transporters And Neurotransmitter Receptors
  • Track 8-3Neural Stem Cells And Gene Or Cell Therapy
  • Track 8-4Neurotransmitters, Neuromodulators, and Neuroreceptors
  • Track 8-5Centrally Acting Analgesics
  • Track 8-6Blood Brain Barrier (BBB)
  • Track 8-7Metabolism Mediated Drug-Drug Interactions
  • Track 8-8Enzyme Kinetics
  • Track 8-9Role Of Drug Metabolism In Drug Development
  • Track 8-10Nanoparticles As Drug Carriers
  • Track 8-11Neurological Drug Targets

Regardless of the type of neuron under consideration, the fundamental steps in chemical transmission are the same. Each of these steps is a potential site for pharmacological intervention in the normal transmission process:

1. Synthesis of the transmitter

2. Storage of the transmitter

3. Release of the transmitter by a nerve action potential

4. Interaction of the released transmitter with receptors on the effector cell membrane and the associated change in the effector cell

5. Rapid removal of the transmitter from the vicinity of the receptors

6. Recovery of the effector cell to the state that preceded transmitter action


  • Track 9-1Dopamine
  • Track 9-2Serotonin
  • Track 9-3Neuropeptides
  • Track 9-4Monoamines
  • Track 9-5Human Synapses
  • Track 9-6Chemical Neurotransmitters
  • Track 9-7Neurotransmission Receptors
  • Track 9-8Advances in Astrocyte-Neuron Interactions in Health and Disease
  • Track 9-9Interneurons: Coordinators of Neuronal Synchrony
  • Track 9-10Drug interaction in Various Stages in Neurotransmitters

Neuropharmacology is a branch of study which deals with drugs that affect the nervous system. It is focused on the development of compounds that may be of benefit to individuals who suffer from neurological or psychiatric illness. Neuropharmacology itself came into existence only five decades ago, prior to which there were only four drugs available for nerve disorders: morphine, caffeine, nitrous oxide, and aspirin. In the next 50 years, a new set of drugs such as antihistamines, barbiturates, and opioid analogs have emerged

  • Track 10-1Molecular and Behavioural Neuropharmacology
  • Track 10-2Clinical Neuropharmacology
  • Track 10-3Antipsychotic drugs/ Neuroleptics
  • Track 10-4Physical Therapy
  • Track 10-5Surgical Aggression and Anesthesia
  • Track 10-6Clinical Pharmacists
  • Track 10-7Neural Circuits Regulating Appetite
  • Track 10-8Avalilable Therapeutics
  • Track 10-9Neuroethics
  • Track 10-10Future Aspects of Neuropharmacology

Neuroimmunology is a field combining neuroscience, the study of the nervous system, and immunology, the study of the immune system. Neuroimmunologists seek to better understand the interactions of these two complex systems during development, homeostasis, and response to injuries.


  • Track 11-1Epigenetics of Neuroimmunology
  • Track 11-2Pediatric Neuro-immunology
  • Track 11-3Neuroimmuno Genetics
  • Track 11-4Neurodevelopmental Diseases and Thermogenesis
  • Track 11-5Autoimmune Neuropathies
  • Track 11-6Antibody-mediated Disorders
  • Track 11-7Neuroimmunology Test
  • Track 11-8Psychoneuroimmunology
  • Track 11-9Neuromics, Neuroproteomics, Neurogenomics and Human Brain Proteome

Child neurology, also known as paediatric neurology, specializes in the diagnosis and management of neurologic conditions during the neonatal period, infancy, early childhood, and adolescence. Child neurologists have special competence in the genetic and metabolic problems, malformations, and developmental problems of childhood, including epilepsy, cerebral palsy, muscular dystrophy, mental retardation, autism, Tourette's syndrome, Batten's disease, neurofibromatosis, learning disabilities, complex metabolic disorders, and a host of nerve and muscle diseases. Child neurologists act as consultants to primary care physicians as well as provide continuing care for chronic neurological conditions. Like other paediatric specialties, it is a specialty that requires the ability to work with patients who may have limited or non- existent verbal skills.


  • Track 12-1Congenital Hydrocephalus
  • Track 12-2Neonatal Encephalopathy
  • Track 12-3Hereditary Ataxy
  • Track 12-4Neural Rube Defects
  • Track 12-5Attention Deficit Hyperactivity Disorder (ADHD)
  • Track 12-6Pediatrics Tumours
  • Track 12-7Pediatric Vestibular Disorders
  • Track 12-8Pediatric Neurology Practice
  • Track 12-9Clinical Trials for Pediatric Epilepsy
  • Track 12-10Advance treatment of Pediatric Neurological Disorders

Neurodegenerative disorders encompass a wide range of conditions that result from progressive damage to cells and nervous system connections that are essential for mobility, coordination, strength, sensation, and cognition. Neurodegenerative diseases affect millions of people worldwide. Although there isn’t a complete cure for most of these complex neurological diseases


  • Track 13-1Alzheimer Disease
  • Track 13-2Parkinsonism
  • Track 13-3Multiple Sclerosis Disease
  • Track 13-4Frontotemporal Lobar Degeneration
  • Track 13-5Schizophrenia
  • Track 13-6Autism
  • Track 13-7Migraine and Headaches
  • Track 13-8Amyotrophic Lateral Sclerosis Disease
  • Track 13-9Prion disease
  • Track 13-10Werdnig-Hoffmann Disease
  • Track 13-11Neuroinflammation Diseases
  • Track 13-12Huntington Disease

Spinal cord disorders can cause permanent severe problems, such as paralysis or impaired bladder and bowel control (urinary incontinence and fecal incontinence). Sometimes these problems can be avoided or minimized if evaluation and treatment are done quickly. Causes of spinal cord disorders include injuries, infections, a blocked blood supply, and compression by a fractured bone or a tumour. Typically, muscles are weak or paralyzed, sensation is abnormal or lost, and controlling bladder and bowel function may be difficult. Doctors base the diagnosis on symptoms and results of a physical examination and imaging tests, such as magnetic resonance imaging.


  • Track 14-1Arachnoiditis
  • Track 14-2Cauda Equina Syndrome
  • Track 14-3Spinal Stenosis
  • Track 14-4Sciatica
  • Track 14-5Scoliosis Spine
  • Track 14-6Spinal stroke
  • Track 14-7Spina Bifida
  • Track 14-8Syringomyelia
  • Track 14-9Transverse Myelitis
  • Track 14-10Spine Tumors
  • Track 14-11Spinal Disorders Test
  • Track 14-12Therapeutic Approaches for Spinal Disorders

Diagnosing a brain tumour usually begins with magnetic resonance imaging (MRI). Once MRI shows that there is a tumour in the brain, the most common way to determine the type of brain tumour is to look at the results from a sample of tissue after a biopsy or surgery.


  • Track 15-1Neurology of Brain
  • Track 15-2Neurobiology of Tumours
  • Track 15-3Pathophysiology of Brain Tumours
  • Track 15-4Radiation & Chemotherapy
  • Track 15-5Invasive and Non-Invasive Imaging of Tumor
  • Track 15-6Structural & Functional Imaging
  • Track 15-7Brain Imaging Techniques
  • Track 15-8Neuroradiology
  • Track 15-9Neuroimaging Software
  • Track 15-10Novel Treatment Strategies

Your brain is your body’s control centre. It’s part of the nervous system, which also includes the spinal cord and a large network of nerves and neurons. Together, the nervous system controls everything from your senses to the muscles throughout your body. When your brain is damaged, it can affect many different things, including your memory, your sensation, and even your personality. Brain disorders include any conditions or disabilities that affect your brain. This includes conditions that are caused by:

  • illness
  • genetics
  • traumatic injury

These disorders include epilepsy, Alzheimer disease and other dementias, cerebrovascular diseases including stroke, migraine and other headache disorders, multiple sclerosis, Parkinson's disease, neuro infections, brain tumours, traumatic disorders of the nervous system due to head trauma


  • Track 16-1Cerebral Hemorrhage
  • Track 16-2Hypertension
  • Track 16-3Cerebral Embolism
  • Track 16-4Cerebral Aneurysm
  • Track 16-5Stroke and Transient Ischaemic Attack
  • Track 16-6Vascular Malformation
  • Track 16-7Risk factors for Cerebrovascular Diseases
  • Track 16-8Epidemiology of Cerebrovascular Diseases
  • Track 16-9Technological Advances in Vascular Surgery

Most people think of neurosurgery as brain surgery — but it is much more!

It is the medical specialty concerned with the diagnosis and treatment of patients with injury to, or diseases/disorders of the brain, spinal cord and spinal column, and peripheral nerves within all parts of the body. The specialty of neurosurgical care includes both adult and paediatric patients. Dependent upon the nature of the injury or disease a neurological surgeon may provide surgical and/or non-surgical care.


  • Track 17-1Post-Surgical Neuralgias
  • Track 17-2Tumour and Metastatis
  • Track 17-3Current Neurosurgery Methods
  • Track 17-4Vascular Malfunctions and Surgery
  • Track 17-5Anatomical and Functional Neural Circuits
  • Track 17-6Neurosurgery Diagnostic Tests
  • Track 17-7Neuropathology

Central nervous system diseases, also known as central nervous system disorders, are a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS)


  • Track 18-1Brain Dysfunction
  • Track 18-2Brain Infections and Abscess
  • Track 18-3Cerebral Edema
  • Track 18-4Fibromyalgia Syndrome
  • Track 18-5Functional and Structural Disorders
  • Track 18-6Arnold–Chiari Malformation
  • Track 18-7Case studies on Spinal Disorders
  • Track 18-8Encephalitis
  • Track 18-9Neuronal and Axonal Damages
  • Track 18-10Neuromyelitis Optica
  • Track 18-11Spinal Meningitis
  • Track 18-12Hydrocephalus
  • Track 18-13White Matter Diseases
  • Track 18-14Pathophysiology of CNS Disorders
  • Track 18-15Cerebellum: Aging and Cognitive Syndrome
  • Track 18-16Holoprosencephaly

Neuro-oncology is a unique, developing neurologic subspecialty that combines many aspects of neurology with those of cancer biology. The neuro-oncologist is expert in both the diagnosis and management of primary brain tumors and neurologic complications of cancer. A career in neuro-oncology presents opportunities to utilize a multidisciplinary team approach and the application of cutting-edge technology toward patient treatment while providing compassionate patient care. Neuro-oncology can trace its modern origins to the 1970s, when the first therapeutic trials were begun. The treatment and management of primary brain Tumors is now a rapidly evolving field.


  • Track 19-1Tumors
  • Track 19-2Malignant brain cancers